| 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis DS Ross, HB Burch, DS Cooper, MC Greenlee, P Laurberg, AL Maia, ... Thyroid 26 (10), 1343-1421, 2016 | 2644 | 2016 |
| Response, Survival, and Long-Term Toxicity After Therapy With the Radiolabeled Somatostatin Analogue [90Y-DOTA]-TOC in Metastasized Neuroendocrine … A Imhof, P Brunner, N Marincek, M Briel, C Schindler, H Rasch, HR Mäcke, ... Journal of clinical oncology 29 (17), 2416-2423, 2011 | 741 | 2011 |
| The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease MA Walter, RA Melzer, C Schindler, J Müller-Brand, A Tyndall, ... European journal of nuclear medicine and molecular imaging 32, 674-681, 2005 | 421 | 2005 |
| Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene F Schiavi, CC Boedeker, B Bausch, M Peçzkowska, CF Gomez, ... Jama 294 (16), 2057-2063, 2005 | 415 | 2005 |
| Prevalence, characteristics, and publication of discontinued randomized trials B Kasenda, E Von Elm, J You, A Blümle, Y Tomonaga, R Saccilotto, ... Jama 311 (10), 1045-1052, 2014 | 352 | 2014 |
| Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials MA Walter, M Briel, M Christ-Crain, SJ Bonnema, J Connell, DS Cooper, ... Bmj 334 (7592), 514, 2007 | 256 | 2007 |
| The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis M Fuchs, M Briel, T Daikeler, UA Walker, H Rasch, S Berg, QKT Ng, ... European journal of nuclear medicine and molecular imaging 39, 344-353, 2012 | 236 | 2012 |
| Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers L Villard, A Romer, N Marincek, P Brunner, MT Koller, C Schindler, ... Journal of Clinical Oncology 30 (10), 1100-1106, 2012 | 229 | 2012 |
| Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out HPH Neumann, Z Erlic, CC Boedeker, LA Rybicki, M Robledo, ... Cancer research 69 (8), 3650-3656, 2009 | 220 | 2009 |
| 1, 2, 3‐Triazoles as amide bond mimics: triazole scan yields protease‐resistant peptidomimetics for tumor targeting IE Valverde, A Bauman, CA Kluba, S Vomstein, MA Walter, TL Mindt Angewandte Chemie International Edition 34 (52), 8957-8960, 2013 | 205 | 2013 |
| Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas BJ Fueger, J Czernin, T Cloughesy, DH Silverman, CL Geist, MA Walter, ... Journal of Nuclear Medicine 51 (10), 1532-1538, 2010 | 185 | 2010 |
| Response to [90Yttrium-DOTA]-TOC Treatment is Associated with Long-term Survival Benefit in Metastasized Medullary Thyroid Cancer: A Phase II Clinical Trial F Iten, B Müller, C Schindler, C Rochlitz, D Oertli, HR Mäcke, ... Clinical Cancer Research 13 (22), 6696-6702, 2007 | 181 | 2007 |
| Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention B Bausch, F Schiavi, Y Ni, J Welander, A Patocs, J Ngeow, U Wellner, ... JAMA oncology 3 (9), 1204-1212, 2017 | 164 | 2017 |
| Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10 K Frank‐Raue, LA Rybicki, Z Erlic, H Schweizer, A Winter, I Milos, ... Human mutation 32 (1), 51-58, 2011 | 159 | 2011 |
| Germline NF1 Mutational Spectra and Loss-of-Heterozygosity Analyses in Patients with Pheochromocytoma and Neurofibromatosis Type 1 B Bausch, W Borozdin, VF Mautner, MM Hoffmann, D Boehm, M Robledo, ... The Journal of Clinical Endocrinology & Metabolism 92 (7), 2784-2792, 2007 | 157 | 2007 |
| Evaluation of [99mTc/EDDA/HYNIC0] octreotide derivatives compared with [111In-DOTA0, Tyr3, Thr8] octreotide and [111In-DTPA0] octreotide: does tumor or pancreas uptake … D Storch, M Béhé, MA Walter, J Chen, P Powell, R Mikolajczak, ... Journal of nuclear medicine 46 (9), 1561-1569, 2005 | 157 | 2005 |
| Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy M Ginj, J Chen, MA Walter, V Eltschinger, JC Reubi, HR Maecke Clinical Cancer Research 11 (3), 1136-1145, 2005 | 155 | 2005 |
| Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study EA Carlsen, N Fazio, D Granberg, S Grozinsky-Glasberg, ... Endocrine-related cancer 26 (2), 227-239, 2019 | 144 | 2019 |
| Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2 CC Boedeker, Z Erlic, S Richard, U Kontny, AP Gimenez-Roqueplo, ... The Journal of Clinical Endocrinology & Metabolism 94 (6), 1938-1944, 2009 | 124 | 2009 |
| Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours S Good, MA Walter, B Waser, X Wang, J Müller-Brand, MP Béhé, ... European journal of nuclear medicine and molecular imaging 35, 1868-1877, 2008 | 114 | 2008 |
